Synthesis, Crystal Structure, Computational Investigation of Vanillin Azine Derivative as Potent Blocker of the N‐Terminal Ras‐Binding Domain (RBD) in Human a‐Raf Kinase.

Vanillin is the main component of natural vanilla extract and is responsible for its flavoring properties. Besides its well‐known applications as an additive in food and cosmetics. In this, we have synthesized a new vanillin derivative. Its structure was characterized by IR, MS, NMR and confirmed by single‐crystal X‐ray analysis. The asymmetric unit of the title molecule consists of two independent half molecules, each having crystallographically imposed centrosymmetry. Reticular layers approximately parallel to the bc plane are generated from one molecule through O−H⋅⋅⋅N hydrogen bonds. The layers are linked by the second molecule through O−H⋅⋅⋅O hydrogen bonds to form a 3‐D network structure. We carried out density functional investigations to understand the compound's molecular reactivity and chemical stability. Frontier molecular orbital (FMO) analysis, global reactivity, and Fukui parameters were calculated at the B3LYP/6‐31+G(d,p) method. In 20 % to 30 % of human malignancies, RAS genes are activated ontogenetically by point mutations. New strategies to block this oncogenic protein are needed since it has proven difficult to create efficient RAS inhibitors. The above‐titled compound shows better structural activity relationship studies against Ras‐binding domine, based on this molecular docking simulation as well as the drug‐likeness analysis carried out for our newly synthesized compound. [ABSTRACT FROM AUTHOR]